A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer

Makaleler > Özet · 2011

Yazarlar: Suzan YALÇIN, RÜÇHAN USLU, F. DANE, U. YILMAZ, N. ZENGIN, E. BUYUKUNAL, S. BUYUKBERBER, C. CAMCI, O. SENCAN, S. KILICKAP

JOURNAL OF CLINICAL ONCOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2011, cilt 29, ss 474-474

DOI: 10.1200/jco.2011.29.4_suppl.474

Detay görüntüle